Published in Rev Rhum Engl Ed on June 01, 1998
Chest wall metastasis from unknown primary site of hepatocellular carcinoma. World J Gastroenterol (2006) 1.02
Inflammatory sternal metastasis heralding lung cancer: two cases. Clin Rheumatol (2005) 0.81
Nodular sclerosing Hodgkin's lymphoma presenting with a pseudo-breast mass extending from a necrotizing granulomatous mediastinal tumor. Hawaii J Med Public Health (2012) 0.78
A rare case of sternal erosion due to bronchogenic carcinoma. Ethiop J Health Sci (2014) 0.75
Mucinous adenocarcinoma presenting as an isolated sternal metastasis. World J Surg Oncol (2007) 0.75
A chest wall pulsating mass. BMJ Case Rep (2015) 0.75
Absent sternum as the first manifestation of bone metastasis on bone scintigraphy. Nucl Med Mol Imaging (2010) 0.75
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2011) 4.78
ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2005) 4.31
Rituximab in CD20 positive multiple myeloma. Leukemia (2007) 2.11
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis (2004) 2.06
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Ann Rheum Dis (2010) 1.59
Minor clone provides a reservoir for relapse in multiple myeloma. Leukemia (2012) 1.54
Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases. Clin Exp Rheumatol (2008) 1.52
Prospective study of the prevalence of bronchiectasis in rheumatoid arthritis using high-resolution computed tomography. Rev Rhum Engl Ed (1998) 1.43
Spondylodiscitis due to Propionibacterium acnes: report of twenty-nine cases and a review of the literature. Clin Microbiol Infect (2009) 1.41
Bilateral frozen shoulder at the same time in two brothers. Rev Rhum Engl Ed (1999) 1.40
Rheumatoid arthritis and bronchiectasis. A retrospective study of fourteen cases. Rev Rhum Engl Ed (1996) 1.40
Immunological follow-up of 17 patients with rheumatoid arthritis treated in vivo with an anti-T CD4+ monoclonal antibody (B-F5) Clin Exp Rheumatol (1992) 1.39
Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis. Arthritis Rheum (2001) 1.30
Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis. Ann Rheum Dis (2007) 1.14
Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study. Rheumatology (Oxford) (2002) 1.12
High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies. Clin Exp Immunol (2003) 1.09
Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy. Ann Rheum Dis (2005) 1.08
Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford) (1999) 1.07
High-dose darbepoetin alpha in the treatment of anaemia of lower risk myelodysplastic syndrome results of a phase II study. Br J Haematol (2006) 1.07
Spondylodiscitis in SAPHO syndrome. A series of eight cases. Ann Rheum Dis (1997) 1.06
Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphoma. Ann Oncol (2003) 0.98
Eighteen cases of crowned dens syndrome: Presentation and diagnosis. Neurochirurgie (2013) 0.98
Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis. Rheumatology (Oxford) (2004) 0.97
Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab Registry. Arthritis Care Res (Hoboken) (2012) 0.96
Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology (Oxford) (2001) 0.95
Degenerative spondylolisthesis, synovial cyst of the zygapophyseal joints, and sciatic syndrome: report of two cases and review of the literature. Arthritis Rheum (1988) 0.94
Surgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: an observational study on 50 surgical procedures. Ann Rheum Dis (2005) 0.93
Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis. Rheumatology (Oxford) (1999) 0.92
Abnormal autonomic cardiovascular control in ankylosing spondylitis. Ann Rheum Dis (1999) 0.92
TAP1 and TAP2 gene polymorphism in rheumatoid arthritis in a population in eastern France. Eur J Immunogenet (2002) 0.91
Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology. Ann Rheum Dis (2005) 0.90
Sarcoidosis and spondylarthropathy. Three case-reports. Rev Rhum Engl Ed (1996) 0.90
Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein Gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis. Ann Rheum Dis (2000) 0.88
Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondyloarthropathy. J Rheumatol (1997) 0.87
[Bone involvement in primary oxalosis. Study of 20 cases]. Rev Rhum Mal Osteoartic (1991) 0.86
Soluble intercellular adhesion molecule 1 in spondylarthropathies. Clin Rheumatol (1998) 0.85
[Osteoporosis in ankylosing spondylitis]. Presse Med (1996) 0.84
[IgA nephropathy and ankylosing spondylitis]. Rev Rhum Mal Osteoartic (1988) 0.84
Lack of association between HLA DRB1* alleles and RS3PE syndrome. Ann Rheum Dis (1998) 0.84
Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry. Ann Rheum Dis (2010) 0.84
Current guidelines for the drug treatment of ankylosing spondylitis. Drugs (1998) 0.83
Pneumococcal polyarticular septic arthritis in a patient with rheumatoid arthritis. Rev Rhum Engl Ed (1999) 0.83
Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-up. Rheumatology (Oxford) (2006) 0.82
HLA-DRB1 alleles and shared amino acid sequences in disease susceptibility and severity in patients from eastern France with rheumatoid arthritis. J Rheumatol (1999) 0.82
[Chronic polyradiculoneuropathy in a patient with Hodgkin's disease]. Rev Med Interne (2001) 0.82
HLA-DR polymorphism influences T-cell precursor frequencies to Epstein-Barr virus (EBV) gp110: implications for the association of HLA-DR antigens with rheumatoid arthritis. Tissue Antigens (1999) 0.82
[Role of the intestine in the physiopathology of inflammatory rheumatism]. Rev Rhum Mal Osteoartic (1992) 0.82
Safety of surgery after rituximab therapy in 133 patients with rheumatoid arthritis: data from the autoimmunity and rituximab registry. Arthritis Care Res (Hoboken) (2013) 0.81
Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study. Bone Marrow Transplant (1998) 0.81
Intestinal permeability in ankylosing spondylitis. J Rheumatol (1990) 0.81
[The immunogenetics of ankylosing spondylitis]. Rev Med Interne (2006) 0.80
From polycystic bone angiomatosis to Gorham's disease. Two case-reports and literature review. Rev Rhum Engl Ed (1998) 0.80
[Bone and visceral manifestations of lipoatrophic diabetes. Apropos of a case]. Rev Rhum Mal Osteoartic (1992) 0.80
The association of HLA-DM genes with rheumatoid arthritis in Eastern France. Hum Immunol (2000) 0.80
Giant calcification in soft tissue after shoulder corticosteroid injection. J Rheumatol (1996) 0.80
[Articular and periarticular manifestations of chronic hemodialysis in the adult]. Rev Rhum Mal Osteoartic (1986) 0.80
Primary biliary cirrhosis and systemic lupus erythematosus. A new case report. Rev Rhum Engl Ed (1998) 0.80
Eruptive pyogenic granulomas and acne fulminans in two siblings treated with isotretinoin. A possible common pathogenesis. Dermatologica (1988) 0.80
Intra-abdominal localization of acute leukaemia: report of six cases. Nouv Rev Fr Hematol (1995) 0.80
Microcirculation in ankylosing spondylitis. Ann Rheum Dis (1994) 0.79
[Paradoxical cutaneous manifestations during anti-TNF-alpha therapy]. Ann Dermatol Venereol (2009) 0.79
Insulin-like growth factor-I and insulin-like growth factor binding protein-3 serum levels in ankylosing spondylitis. Br J Rheumatol (1998) 0.79
Rheumatoid arthritis and multiple sclerosis in the same patient. Two case-reports. Rev Rhum Engl Ed (1999) 0.79
[Neural determination in Xenopus laevis embryos: control of early neural gene expression by calcium]. J Soc Biol (2001) 0.79
Factors linked to disease activity in a French cohort of patients with spondyloarthropathy. J Rheumatol (1998) 0.79
[Streptococcus faecalis: sensitivity to quinolones, penicillins and aminoglycosides alone or in combination]. Pathol Biol (Paris) (1986) 0.78
Crohn's disease associated with seropositive rheumatoid arthritis. Clin Exp Rheumatol (1997) 0.78
Herpes virus-related lymphoproliferative disorders following allogeneic bone marrow transplantation: clinical and biological characteristics of six cases. Nouv Rev Fr Hematol (1995) 0.78
Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: the Besançon experience. Immunol Rev (1992) 0.78
Reiter's syndrome induced by Gardnerella vaginalis. Scand J Rheumatol (1998) 0.78
Transient efficacy of pulse pamidronate treatment in active spondylarthropathies: an open study of 35 cases. Clin Exp Rheumatol (2006) 0.78
The B7 cross reactive group and spondyloarthropathies: an epidemiological approach. J Rheumatol (1995) 0.78
Non-radiographic axial spondyloarthritis: what is it? Clin Exp Rheumatol (2013) 0.78
[Infectious osteoarthritis due to Propionibacterium acnes. Two new cases]. Rev Med Interne (2000) 0.78
Increased frequency of HLA-DRB1*0401 in patients with RA and bronchiectasis. Ann Rheum Dis (2000) 0.78
Combination therapy of anti-CD4 and anti-IL6 monoclonal antibodies in a case of severe spondylarthropathy. Br J Rheumatol (1996) 0.77
Therapeutic advances in ankylosing spondylitis. Expert Opin Investig Drugs (2001) 0.77
Bone metastases from a paraganglioma. A review of five cases. Rev Rhum Engl Ed (1999) 0.77
Amyloid arthropathy revealed by RS3PE syndrome. Joint Bone Spine (2000) 0.77
Fibromyalgia developed after administration of gonadotrophin-releasing hormone analogue. Clin Rheumatol (2001) 0.77
HLA DRB1* alleles in rheumatoid nodulosis: a comparative study with rheumatoid arthritis with and without nodules. Rheumatol Int (1998) 0.77
Absence of relation between TGF beta 1 serum levels and bone mass in ankylosing spondylitis patients. Clin Exp Rheumatol (2000) 0.77
[Hypercalcemia of double origin: association of multiple myeloma and ectopic parathyroidal adenoma]. Rev Med Interne (2007) 0.76
Cyclosporine: a new adjuvant therapy for giant cell arteritis? Arthritis Rheum (1985) 0.76
Sjögren's syndrome occurring after hepatitis B vaccination. Arthritis Rheum (2000) 0.76
The purification of CD34 cells from human cord blood: comparison of separation techniques and cytokine requirements for optimal growth of clonogenic progenitors. Br J Haematol (1996) 0.76
FDG-PET/CT scan of inflammatory spondylodiscitis lesions in ankylosing spondylitis, and short term evolution during anti-tumour necrosis factor treatment. Ann Rheum Dis (2005) 0.76
Early intensive therapy with autologous stem cell transplantation in advanced Hodgkin's disease: retrospective analysis of 158 cases from the French registry. Bone Marrow Transplant (1998) 0.75
Decreased levels of serum soluble HLA class I antigens in HLA-B27 positive spondyloarthropathies. Ann Rheum Dis (2006) 0.75
Natural killer cell function in ankylosing spondylitis. Ann Rheum Dis (1988) 0.75
[Rheumatoid synovial cyst of the hip. Apropos of a case]. Rev Rhum Mal Osteoartic (1987) 0.75
Calcified synovial cysts of zygapophyseal joints. J Rheumatol (1994) 0.75
Prevention of veno-occlusive disease of the liver after bone marrow transplantation: heparin or no heparin? Blood (1992) 0.75
IL-2 treatment after autologous bone marrow transplantation in poor prognosis Hodgkin's disease: defective IL-2-induced LAK activity? Bone Marrow Transplant (1991) 0.75
Tuberculous rheumatism presenting as spondyloarthropathy. J Rheumatol (1999) 0.75
Interleukin-2-induced increase of a monoclonal B-cell lymphocytosis. A novel in vivo interleukin-2 effect? Cancer (1992) 0.75
[Polyarthritis accompanying alveolar echinococcosis or the icing on the cake]. Rev Med Interne (2000) 0.75